Therapeutic Outcomes Using Contact Force Handling During Atrial Fibrillation Ablation

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 120 participants.

Also called NCT01851525

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01851525
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01851525. Randomized; no masking; primary purpose treatment. Start 2013-06 (registry gives no type); primary completion 2017-02-15 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Therapeutic Outcomes Using Contact Force Handling During Atrial Fibrillation Ablation
Acronym
TOUCH AF
Condition
Persistent Atrial Fibrillation
Intervention (Device)
ThermoCoolSmartTouch ablation catheter, Biosense Webster
Lead sponsor
Southlake Health (class: other)
Collaborator
Applied Health Research Centre (class: other)

Record details

Record id
cardio:ct-nct01851525
Content hash
f3370e6e2fcaa773634aa6a6da603e7f67fe9274e6b709bbf5db4f1c5c96d12b